Safer Processing for Therapeutics Targeting Infectious Diseases, Autoimmune Disorders and Cancer
During the COVID-19 epidemic, monoclonal antibodies became a well-known and essential tool for treating the disease. Biologic therapeutics provide promising treatments for all kinds of infectious diseases. However, new research reveals problems that can affect product quality and shelf life.
Researchers at the FAMU-FSU College of Engineering and the National High Magnetic Field Laboratory are working with the National Institute of Health and the National Institute of Allergy and Infectious Diseases (NIAID) to study the problem.
